Uncategorized
Featured Stories
DaVita Inc. 1st Quarter 2026 Results
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita Clinical Research to Present New Findings at American Society of Nephrology Kidney Week 2020
DaVita Clinical Research (DCR) will present 14 research abstracts from company representatives and medical professionals at the American Society of Nephrology (ASN) annual Kidney Week occurring…
-
DaVita Inc. Schedules 3rd Quarter 2020 Investor Conference Call
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Thursday, October 29, 2020, at 5:00 p.m. Eastern Time. The company…
-
DaVita joins Dialysis Patient Citizens in supporting BETTER Kidney Care Act
DaVita joins Dialysis Patient Citizens in supporting BETTER Kidney Care Act Bipartisan, bicameral legislation would improve quality of life for patients with kidney disease DaVita joins…
-
DaVita Announces Final Results Of Self-Tender Offer
DAVITA INC. (NYSE: DVA) (“DaVita”) a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care…
-
DaVita Announces Preliminary Results of Self-Tender Offer
DAVITA INC. (NYSE: DVA) (“DaVita”), a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care…